Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice.
Eva HadadiWilliam TaylorXiao-Mei LiYetki AslanMarthe VilloteJulie RivièreGaelle DuvalletCharlotte AuriauSandrine DulongIsabelle Raymond LetronSylvain ProvotAnnelise Bennaceur-GriscelliHervé AcloquePublished in: Nature communications (2020)
Breast cancer is the most common type of cancer worldwide and one of the major causes of cancer death in women. Epidemiological studies have established a link between night-shift work and increased cancer risk, suggesting that circadian disruption may play a role in carcinogenesis. Here, we aim to shed light on the effect of chronic jetlag (JL) on mammary tumour development. To do this, we use a mouse model of spontaneous mammary tumourigenesis and subject it to chronic circadian disruption. We observe that circadian disruption significantly increases cancer-cell dissemination and lung metastasis. It also enhances the stemness and tumour-initiating potential of tumour cells and creates an immunosuppressive shift in the tumour microenvironment. Finally, our results suggest that the use of a CXCR2 inhibitor could correct the effect of JL on cancer-cell dissemination and metastasis. Altogether, our data provide a conceptual framework to better understand and manage the effects of chronic circadian disruption on breast cancer progression.
Keyphrases
- stem cells
- mouse model
- papillary thyroid
- epithelial mesenchymal transition
- squamous cell carcinoma
- induced apoptosis
- metabolic syndrome
- cell death
- physical activity
- electronic health record
- drug induced
- polycystic ovary syndrome
- depressive symptoms
- oxidative stress
- insulin resistance
- human health
- young adults
- sleep quality